KCNQ4 Polyclonal Antibody

Background:
The protein encoded by this gene forms a potassium channel that is thought to play a critical role in the regulation of neuronal excitability, particularly in sensory cells of the cochlea. The current generated by this channel is inhibited by M1 muscarinic acetylcholine receptors and activated by retigabine, a novel anti-convulsant drug. The encoded protein can form a homomultimeric potassium channel or possibly a heteromultimeric channel in association with the protein encoded by the KCNQ3 gene. Defects in this gene are a cause of nonsyndromic sensorineural deafness type 2 (DFNA2), an autosomal dominant form of progressive hearing loss. Two transcript variants encoding different isoforms have been found for this gene.

Research Area: Cancer, Neuroscience

Synonyms:
DFNA 2, DFNA2, KCNQ 4, Kcnq4, KCNQ4, KQT like 4, KQT-like 4, KV7.4, Potassium channel KQT like 4, Potassium channel subunit alpha KvLQT4, Potassium voltage gated channel KQT like protein 4, Potassium voltage gated channel KQT like subfamily member 4, Potassium voltage gated channel subfamily KQT member 4, Potassium voltage-gated channel subfamily KQT member 4, Voltage gated potassium channel subunit Kv7.4, Voltage-gated potassium channel subunit Kv7.4

Immunogen: Synthetic peptide of human KCNQ4

Swissprot: P56696
Gene Accession: NP_004691

Calculated MW: 77 kDa

Purification Method: Affinity purification

Buffer: PBS with 0.05% sodium azide and 50% glycerol, PH7.4

Concentration: 0.9 mg/mL
Dilution: WB 1:200-1:1000, IHC 1:50-1:200

Storage:
Store at -20°C. Avoid freeze / thaw cycles.

Alternative for product with catalog number:
sc-12442/sc-20882/sc-50417